Submission Details
| 510(k) Number | K032575 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | August 20, 2003 |
| Decision Date | May 19, 2004 |
| Days to Decision | 273 days |
| Submission Type | Traditional |
| Review Panel | Chemistry (CH) |
| Summary | Summary PDF |
K032575 is an FDA 510(k) clearance for the FIRST SIGN DRUG OF ABUSE SCREENING TEST, a Enzyme Immunoassay, Amphetamine (Class II — Special Controls, product code DKZ), submitted by W.H.P.M., Inc. (Beverly, US). The FDA issued a Cleared decision on May 19, 2004, 273 days after receiving the submission on August 20, 2003. This device falls under the Chemistry review panel. Regulated under 21 CFR 862.3100.
| 510(k) Number | K032575 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | August 20, 2003 |
| Decision Date | May 19, 2004 |
| Days to Decision | 273 days |
| Submission Type | Traditional |
| Review Panel | Chemistry (CH) |
| Summary | Summary PDF |
| Product Code | DKZ — Enzyme Immunoassay, Amphetamine |
| Device Class | Class II — Special Controls |
| CFR Regulation | 21 CFR 862.3100 |